Strategic partnership Sedia Biosciences recently partnered with Thermo Fisher Scientific to become a global authorized distributor for AgriSeq products under a co-exclusive distribution agreement, signaling interest in expanding global reach and channel partnerships that sales teams can leverage for co-selling opportunities and cross-promotion.

WHO pre-qualification The company achieved WHO pre-qualification for its Asanté HIV-1/2 Oral Fluid Test, which can open doors to procurement opportunities in global health programs, NGOs, and government tenders where validated, globally accepted diagnostics are prioritized.

ISO certification Having ISO 13485 certification strengthens quality and regulatory credibility for HIV diagnostics and related devices, enabling pursuit of larger, quality-focused customers and international contracts that require robust quality management systems.

Global access focus Sedia emphasizes rapid point-of-care and remote specimen collection solutions, presenting a sales angle to health systems, clinics, and mobile testing programs seeking convenient, decentralized testing workflows and alternative fluid specimen assays.

Growth readiness With moderate revenue range and recent expansions in product credentials and partnerships, there is opportunity to upsell enhanced diagnostic services, sequencing offerings, and regional distribution to expand market share in infectious disease testing and epidemiological surveillance.